Dr. Rohit Kumar Garg

About Doctor

Dr. Rohit Kumar Garg is one of the most contemporary infectious diseases expert trained in Internal medicine and Infectious disease at the most prestigious institute in the country (AIIMS, New Delhi). Amongst the few of his counterparts, he is passionate about delivering impeccable care to patients with any kind of community or hospital-acquired infections (including COVID-19), HIV, Tuberculosis, fungal infections, infections in immunocompromised patients, and, Hematopoietic stem cell and Solid organ transplant recipients. He has a special interest in cases of PUO (prolonged fever), tropical fevers, difficult-to-treat-resistance cases, and infections in the immunocompromised population. He has attained explicit training in diagnostic and anti-microbial stewardship as well as hospital infection control. He believes in scientific evidenced based patient care. He has a keen interest in education and training, academics, as well as scientific research. Besides healthcare, he is a keen observer, a humble, kind-hearted person and high on morals.

• DM (Infectious diseases), AIIMS, New Delhi
• MBBS (Government medical college, Haldwani, Uttaranchal)

• He has expertise in diagnosing and managing Community-acquired infection syndromes (infections of the respiratory tract, CNS, urinary tract, bone and joint, skin and soft tissue, G.I tract, and intra-abdominal infections (including abscesses, COVID-19, Monkeypox).
• Tropical infections (eg viral - dengue, Chikungunya, Zika , Bacterial - enteric fever, leptospirosis, scrub typhus, Brucellosis, melioidosis, syphilize Parasitic -malaria, Leishmaniasis Kala-azar, Amoebiasis, Hydatid diseases, Cysticercosis Fungal – mycetoma, chromoblastomycosis etc.)
• Nosocomial infections including sepsis, difficult to treat infections, multidrug-resistant bugs related infections, post-surgical infections,Tuberculosis (Pulmonary, EPTB, drug susceptible, MDR/XDR TB), Non-tubercular mycobacterial (NTM) infections.
• Fungal infections (eg Mucormycosis, Aspergillosis, Candidiasis, Histoplasmosis, Cryptococcosis, Phaeohyphomycosis, Entomophoromycosis, Other endemic and emerging fungal infections)
• Infections in immunocompromised patients (HIV, malignancy, primary immunodeficiency disorders, HSCT/SOT recipients) eg CMV, Nocardiosis, Toxoplasmosis, HSV, Zoster etc.
• Adult immunization and Travel health advice.
• Antimicrobial stewardship.
• Hospital Infection Control.

• AHA accredited BLS/ACLS provider course – American Heart Association-Max Healthcare Institute, India, 2022.
• Diagnostic and Interventional Bronchoscopy and Thoracoscopy – IMMAST, 2022.
• ESCMID 20th Summer School, Rome, Italy (July 2022).
• Tropical Parasitology: Protozoans, Worms, Vectors and Human Diseases – Duke university, 2022·
• Neurological Infectious diseases course (University of Liverpool & CMC Vellore, 2019
• Ist prize in ID quiz in CIDSCON Infections diseases conferences, 2016 (Vellore).
• 2nd prize in Transplant ID conference CAST 2019 (NOIDA)·
• Has been awarded attendance grant for attending ESCMID 20th Summer School, Rome, Italy (July, 2022).
• Has been selected to present research idea in RSTMH research show case ideas, 2019 (New Delhi).

• Sirohiya P, Elavarasi A, Sagiraju HKR, Baruah M, Gupta N, Garg RK, et al. Silent Hypoxia in Coronavirus disease-2019: Is it more dangerous? -A retrospective cohort study. Lung India. 2022 Jun;39(3):247–53.
• Desai D, Khan AR, Soneja M, Mittal A, Naik S, Kodan P,[…] Kumar R et al. Effectiveness of an inactivated virus-based SARS-CoV-2 vaccine, BBV152, in India: a test-negative, case-control study. The Lancet Infectious Diseases [Internet]. 2021 Nov 23 [cited 2022 Jan 12];0(0). Available from: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00674-5/fulltext
• Arora U, Priyadarshi M, Katiyar V, Soneja M, Garg P, Gupta I, [….] Garg R K, et al. Novel risk factors for Coronavirus disease-associated mucormycosis(CAM): a case-control study during the outbreak in India. Journal of Infection [Internet]. 2021 Dec 30 [cited 2022 Jan 12];0(0). Available from: https://www.journalofinfection.com/article/S0163-4453(21)00654-X/fulltext.
• Elavarasi A, Sagiraju HKR, Garg RK, Ratre B, Sirohiya P, Gupta N, et al. Clinical features, demography, and predictors of outcomes of SARS-CoV-2 infection at a tertiary care hospital in India: A cohort study. Lung India. 2022 Feb;39(1):16–26.
• Paul SS, Lal BM, Ray A, Meena VP, Garg RK, Tiwari P, et al. Pneumothorax and pneumomediastinum in patients with COVID-19: A retrospective study from tertiary care institute in India. : Drug Discov Ther. 2021;15(6):310-316. (DOI: 10.5582/ddt.2021.01105)